CLINICAL INNOVATION ApS: Financial statements 2012
CVR: 29924880
Source: annual report 2012, Danish Business Authority
01/10/2011 – 30/09/2012
CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,368,366 and a net result of DKK 550,359. Equity in the 2012 report amounted to DKK 2,428,161. The solvency ratio was 50.4%.
- Gross Profit
- DKK 2,368,366
- Profit/Loss
- DKK 550,359
- Equity
- DKK 2,428,161
- Total Assets
- DKK 4,819,484
Official annual report
Keep an eye on CLINICAL INNOVATION ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lorentzen Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.